Skip to main content
Skip to main content
USNA logo

USANA Health Sciences, Inc. (USNA)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

USANA Health Sciences, Inc. (USNA) trades at $17.01 with AI Score 50/100 (Hold). USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. Market cap: $313.95M, Sector: Consumer defensive.

Last analyzed: Feb 8, 2026
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company operates through direct sales in the Asia Pacific, the Americas, and Europe.
50/100 AI Score Target $39.00 (+129.3%) MCap $313.95M Vol 89.3K

USANA Health Sciences, Inc. (USNA) Consumer Business Overview

CEOKevin G. Guest
Employees1700
HeadquartersSalt Lake City, UT, US
IPO Year1994

USANA Health Sciences offers investors a notable opportunity to tap into the growing health and wellness market through its direct-selling model and science-backed nutritional products, targeting diverse age groups and health needs with a strong presence in Asia Pacific.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Investing in USANA Health Sciences presents a notable opportunity due to the company's established presence in the growing nutritional and personal care market. With a market capitalization of $0.39 billion and a gross margin of 76.1%, USANA demonstrates financial stability and profitability. The company's direct-selling model provides a scalable distribution network, particularly in the Asia Pacific region, which represents a significant growth driver. The company's commitment to science-based formulations and research collaborations, such as the agreement with Beijing University of Chinese Medicine, enhances its credibility and product differentiation. USANA's P/E ratio of 22.94 suggests a reasonable valuation relative to its earnings. Continued expansion in key markets and innovation in product development are expected to drive revenue growth and shareholder value.

Based on FMP financials and quantitative analysis

Key Highlights

  • Gross Margin of 76.1% indicates strong pricing power and efficient cost management.
  • Market Cap of $0.39B reflects the company's current valuation in the market.
  • P/E Ratio of 22.94 suggests a reasonable valuation compared to its earnings.
  • Presence in Asia Pacific, the Americas, and Europe provides geographic diversification.
  • Direct-selling model enables scalable distribution and entrepreneurial opportunities.

Competitors & Peers

Strengths

  • Science-backed product formulations.
  • Direct-selling distribution model.
  • Global presence in key markets.
  • Strong brand reputation.

Weaknesses

  • Reliance on direct-selling model can be susceptible to regulatory changes.
  • Profit margin of 1.9% is relatively low compared to peers.
  • Limited dividend payout may deter some investors.
  • Potential for negative publicity related to direct-selling practices.

Catalysts

  • Expansion into new geographic markets, particularly in Asia Pacific.
  • Product innovation and development of new supplement formulations.
  • Launch of new e-commerce initiatives to drive online sales.
  • Strategic partnerships with healthcare providers and wellness influencers.

Risks

  • Regulatory changes affecting the direct-selling industry.
  • Negative publicity related to product safety or efficacy.
  • Economic downturns impacting consumer spending on discretionary items.
  • Intense competition from other nutritional supplement companies.
  • Fluctuations in currency exchange rates affecting international sales.

Growth Opportunities

  • Expansion in Asia Pacific: USANA has a significant opportunity to further expand its presence in the Asia Pacific region, where demand for nutritional supplements and personal care products is rapidly growing. The region's large population and increasing disposable incomes create a favorable market for USANA's products. By strengthening its distribution network and tailoring its product offerings to local preferences, USANA can capture a larger share of this market.
  • Product Innovation: Investing in research and development to create innovative and science-backed products can drive growth. The company's research collaboration agreement with Beijing University of Chinese Medicine can lead to the development of new products based on traditional Chinese medicine, which could appeal to a broader customer base. New products targeting specific health needs or age groups can also attract new customers and increase sales.
  • E-commerce Growth: Enhancing its online presence and e-commerce capabilities can enable USANA to reach a wider audience and increase sales. Investing in user-friendly website design, mobile apps, and digital marketing can improve the customer experience and drive online sales. Offering personalized product recommendations and subscription services can also enhance customer loyalty and increase repeat purchases.
  • Personalized Nutrition: The growing trend of personalized nutrition offers a significant growth opportunity for USANA. By offering customized supplement recommendations based on individual health needs and preferences, USANA can differentiate itself from competitors and attract customers seeking personalized solutions. This can be achieved through online assessments, DNA testing, and consultations with healthcare professionals.
  • Strategic Partnerships: Forming strategic partnerships with healthcare providers, fitness centers, and wellness influencers can expand USANA's reach and credibility. Collaborating with these partners to promote USANA's products and educate consumers about the benefits of nutrition and personal care can drive sales and brand awareness. These partnerships can also provide access to new customer segments and distribution channels.

Opportunities

  • Expansion in emerging markets.
  • Development of personalized nutrition products.
  • Increased focus on e-commerce and digital marketing.
  • Strategic partnerships with healthcare providers.

Threats

  • Intense competition in the nutritional supplement industry.
  • Changing consumer preferences and trends.
  • Regulatory scrutiny of direct-selling practices.
  • Economic downturns affecting consumer spending.

Competitive Advantages

  • Science-based formulations: Focus on research and development provides a competitive edge.
  • Direct-selling model: Creates a loyal customer base and scalable distribution network.
  • Global presence: Diversifies revenue streams and reduces reliance on any single market.
  • Brand reputation: Established brand with a reputation for quality and efficacy.

About USNA

USANA Health Sciences, Inc., founded in 1992 and headquartered in Salt Lake City, Utah, is a developer, manufacturer, and direct seller of science-based nutritional and personal care products. The company's foundation lies in its commitment to providing high-quality supplements and skincare solutions designed to enhance overall health and well-being. USANA's product portfolio includes USANA nutritional products, featuring essentials/CellSentials, vitamin and mineral supplements catering to various age groups, and optimizers, targeted supplements addressing cardiovascular, skeletal/structural, and digestive health needs. Additionally, the company offers a range of foods, including meal replacement shakes and snack bars. Expanding beyond nutrition, USANA provides Celavive, a comprehensive skin care regimen formulated for diverse skin types and ethnicities. The company also offers specialized products for prenatal, infant, and young child age groups, demonstrating its commitment to supporting health at every stage of life. USANA operates through a direct-selling model, empowering associates to build their own businesses by marketing and distributing the company's products. The company supports its associates with materials and online tools to facilitate business development and product promotion. USANA's products are available directly in the Asia Pacific, the Americas, and Europe, as well as through online channels, reflecting its global reach and accessibility. USANA has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine and National Sports Training Bureau.

What They Do

  • Develops and manufactures science-based nutritional supplements.
  • Offers a range of vitamin and mineral supplements for various age groups.
  • Provides targeted supplements for cardiovascular, skeletal, and digestive health.
  • Produces meal replacement shakes and snack bars.
  • Offers Celavive skin care products for different skin types and ethnicities.
  • Sells products directly through associates in Asia Pacific, the Americas, and Europe.
  • Provides online tools and materials to assist associates in building their businesses.

Business Model

  • Direct selling: Products are sold through a network of independent distributors.
  • Product sales: Revenue is generated from the sale of nutritional and personal care products.
  • Global operations: Operates in multiple countries across Asia Pacific, the Americas, and Europe.

Industry Context

USANA Health Sciences operates within the competitive packaged foods and dietary supplements industry, which is experiencing growth driven by increasing consumer awareness of health and wellness. The global dietary supplements market is projected to reach billions of dollars in the coming years. Key trends include the rising demand for personalized nutrition, clean label products, and e-commerce channels. USANA differentiates itself through its science-based formulations, direct-selling model, and global presence, particularly in the Asia Pacific region. Competitors include companies like BGS, BRCC, CVGW, DDL, and LND, which compete for market share through various distribution channels and product offerings.

Key Customers

  • Individuals seeking nutritional supplements for overall health and wellness.
  • Customers looking for targeted supplements for specific health needs.
  • Individuals interested in science-based skin care products.
  • Associates who purchase products for personal use and resale.
AI Confidence: 71% Updated: Feb 8, 2026

Financials

Chart & Info

USANA Health Sciences, Inc. (USNA) stock price: $17.01 (+0.00, +0.00%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for USNA.

Price Targets

Consensus target: $39.00

MoonshotScore

50/100

What does this score mean?

The MoonshotScore rates USNA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About USANA Health Sciences, Inc. (USNA) — Consumer Defensive

What does USANA Health Sciences, Inc. do?

USANA Health Sciences, Inc. is a company that develops, manufactures, and sells science-based nutritional and personal care products. Their offerings include a range of vitamin and mineral supplements, targeted supplements for specific health needs, meal replacement shakes, and skin care products. USANA operates through a direct-selling model, where independent distributors sell products directly to consumers in Asia Pacific, the Americas, and Europe. This model allows for a personal touch in sales and distribution, fostering customer loyalty and brand advocacy, while also offering entrepreneurial opportunities to its distributors.

Is USNA stock worth researching?

USNA stock presents a mixed investment profile. The company's strong gross margin of 76.1% and established presence in the growing nutritional supplement market are positive indicators. However, the relatively low profit margin of 1.9% and lack of dividend payout may deter some investors. The company's P/E ratio of 22.94 suggests a reasonable valuation, but potential investors should carefully consider the risks associated with the direct-selling model and competitive landscape before making a decision. Growth opportunities in Asia Pacific and product innovation could drive future returns.

What are the main risks for USNA?

USANA faces several key risks. The direct-selling business model is subject to regulatory scrutiny and potential changes in regulations, which could impact the company's operations and profitability. Intense competition in the nutritional supplement industry requires USANA to continuously innovate and differentiate its products. Economic downturns could reduce consumer spending on discretionary items like nutritional supplements. Fluctuations in currency exchange rates could affect international sales and profitability. Negative publicity related to product safety or the direct-selling model could also damage the company's reputation and sales.

What are the key factors to evaluate for USNA?

USANA Health Sciences, Inc. (USNA) currently holds an AI score of 50/100, indicating moderate score. The stock trades at a P/E of 24.2x, near the S&P 500 average (~20-25x). Analysts target $39.00 (+129% from $17.01). Key strength: Science-backed product formulations. Primary risk to monitor: Regulatory changes affecting the direct-selling industry. This is not financial advice.

How frequently does USNA data refresh on this page?

USNA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven USNA's recent stock price performance?

Recent price movement in USANA Health Sciences, Inc. (USNA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $39.00 implies 129% upside from here. Notable catalyst: Science-backed product formulations. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider USNA overvalued or undervalued right now?

Determining whether USANA Health Sciences, Inc. (USNA) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 24.2. Analysts target $39.00 (+129% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying USNA?

Before investing in USANA Health Sciences, Inc. (USNA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Stock data pending update may affect valuation metrics.
  • Direct-selling business model inherently carries regulatory risk.
Data Sources

Popular Stocks